Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Drug:  Nrf2 activator RTA 408
Find trials that include:  Any drugs shown
Results 1-1 of 1 for your search:
Start Over
RTA 408 Capsules in Patients With Melanoma - REVEAL
Status: Active
Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: RTA 408-C-1401, NCI-2015-00144, NCT02259231
Start Over